By Counterforce Health Team in Orfadin (nitisinone) —

How to Get Orfadin (nitisinone) Covered by Humana in New York: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Orfadin (nitisinone) Covered by Humana in New York

Humana requires prior authorization for Orfadin (nitisinone) to treat hereditary tyrosinemia type 1 (HT-1). Your fastest path to approval: Gather confirmed HT-1 diagnosis (elevated succinylacetone levels, genetic testing), obtain a medical necessity letter from your prescriber, and submit through Humana's provider portal. If denied, you have 65 days to appeal internally, then 120 days to request external review through New York's Department of Financial Services. Start today: Contact your prescriber to begin the prior authorization process and ensure all diagnostic documentation is complete.

Table of Contents

  1. Understanding Humana's Orfadin Coverage Requirements
  2. Step-by-Step: Fastest Path to Approval
  3. Common Denial Reasons & How to Fix Them
  4. Medical Necessity Letter Essentials
  5. Appeals Process for Humana in New York
  6. External Review Through New York DFS
  7. Cost-Saving Options
  8. Frequently Asked Questions
  9. Sources & Further Reading

Understanding Humana's Orfadin Coverage Requirements

Humana Medicare Advantage and Part D plans classify Orfadin (nitisinone) as a specialty medication requiring prior authorization. The drug is typically placed on higher formulary tiers due to its high cost and limited patient population.

Coverage at a Glance

Requirement What It Means Documentation Needed Timeline
Prior Authorization Must be approved before filling Medical necessity letter, diagnostic tests 5-7 business days
HT-1 Diagnosis Confirmed hereditary tyrosinemia type 1 Elevated succinylacetone, genetic testing At initial request
Dietary Management Evidence of tyrosine/phenylalanine restriction Dietitian consultation notes Initial + renewal
Prescriber Requirements In-network provider must prescribe Provider enrollment verification Before submission
Renewal Period Reauthorization needed Updated labs, clinical response 12-24 months

Source: Humana Medicare Prescription Drug Guide

Step-by-Step: Fastest Path to Approval

1. Confirm Your Diagnosis Documentation

Who does it: Your specialist (metabolic geneticist, hepatologist, or pediatric specialist) What's needed:

  • Elevated succinylacetone levels in blood or urine
  • FAH gene mutation analysis confirming HT-1
  • Clinical notes documenting HT-1 symptoms

2. Verify Network Status

Who does it: You or your clinic What's needed: Confirm your prescriber is in Humana's network using their provider directory Timeline: Complete before PA submission

3. Obtain Medical Necessity Letter

Who does it: Your prescriber What's needed: Detailed letter addressing Humana's specific criteria (see Medical Necessity section below) Timeline: Allow 2-3 business days for completion

4. Submit Prior Authorization

Who does it: Your prescriber or their staff How to submit: Through Humana's provider portal or by fax Timeline: 5-7 business days for standard review, 72 hours for expedited

5. Follow Up on Decision

Who does it: You and your care team What to expect: Written notification of approval or denial Next steps: If approved, fill at preferred pharmacy; if denied, proceed to appeals process

Tip: Request expedited review if you're currently on Orfadin or have urgent medical needs. Humana must respond within 72 hours for expedited requests.

Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn Required Documentation
Insufficient HT-1 diagnosis Provide complete biochemical and genetic testing Succinylacetone levels, FAH gene analysis results
Missing dietary management plan Submit dietitian consultation Formal nutrition assessment and management plan
Prescriber not in network Switch to in-network provider or request exception Network status verification, continuity of care letter
Quantity limits exceeded Justify dosing based on weight/clinical need Weight-based dosing calculations, clinical response data
Step therapy not completed Document contraindications or failure of alternatives Note: Step therapy rarely applies as Orfadin is first-line for HT-1

Source: Humana Medical Coverage Policies

Medical Necessity Letter Essentials

Clinician Corner: Letter Components

Your medical necessity letter should address these key points:

1. Confirmed HT-1 Diagnosis

  • Laboratory results showing elevated succinylacetone
  • Genetic testing confirming FAH gene mutations
  • Clinical presentation consistent with HT-1

2. Medical Necessity Justification

  • Orfadin is the only FDA-approved treatment for HT-1
  • Without treatment, HT-1 progresses to liver failure and death
  • Early intervention prevents irreversible organ damage

3. Dosing and Monitoring Plan

  • Weight-based dosing (typically 0.5 mg/kg twice daily)
  • Regular monitoring of succinylacetone levels
  • Liver function and growth assessments

4. Dietary Management Integration

  • Coordination with registered dietitian
  • Tyrosine and phenylalanine restriction protocol
  • Ongoing nutritional monitoring

5. Alternative Considerations

  • Address why generic nitisinone may not be appropriate (if applicable)
  • Document any previous treatment responses or failures
From our advocates: "We've seen the strongest approvals when providers include specific lab values and reference FDA labeling directly. A generic 'patient needs this medication' letter rarely succeeds with specialty drugs like Orfadin."

Appeals Process for Humana in New York

If your initial prior authorization is denied, New York residents have robust appeal rights through both Humana's internal process and the state's external review system.

Internal Appeals Timeline

First-Level Internal Appeal

  • Deadline to file: 65 days from denial notice
  • Humana's response time: 30 days for standard, 72 hours for expedited
  • How to file: Call Humana member services or submit written appeal

Second-Level Internal Appeal (if applicable)

  • Deadline to file: 65 days from first-level denial
  • Response time: 30 days standard
  • Requirements: Include all previous documentation plus any new evidence

Required Documentation for Appeals

  • Original denial letter
  • Complete medical records supporting HT-1 diagnosis
  • Updated medical necessity letter addressing denial reasons
  • Peer-reviewed literature supporting treatment (if applicable)
  • Any new clinical information since initial request

Source: Humana Appeals Process

External Review Through New York DFS

New York offers one of the nation's most robust external appeal processes through the Department of Financial Services (DFS).

External Appeal Process

Eligibility: Available after receiving a Final Adverse Determination from Humana's internal appeal process

Timeline to File: 120 days from Humana's final denial

DFS Review Timelines:

  • Standard appeals: 30 days
  • Expedited appeals: 72 hours
  • Non-formulary drug appeals: 24-72 hours

How to File External Appeal

  1. Complete the Application: Download the New York State External Appeal Application
  2. Submit Required Documentation:
    • Physician attestation of medical necessity
    • All denial letters from Humana
    • Clinical documentation supporting treatment
    • Relevant medical literature
  3. File Your Appeal:
    • Mail: New York State Department of Financial Services, 99 Washington Avenue, Box 177, Albany, NY 12210
    • Fax: (800) 332-2729

Success Rate: Approximately 45% of external appeals overturn insurance denials in New York.

Cost: Maximum $25 fee (waived for financial hardship)

Source: NY DFS External Appeals

Getting Help with Appeals

Community Health Advocates provides free assistance to all New Yorkers with insurance appeals:

  • Helpline: 888-614-5400 (Monday-Friday, 9 AM-4 PM)
  • Services: Help with internal appeals, external review applications, and gathering documentation
  • Languages: Multilingual support available

Source: Community Health Advocates

Cost-Saving Options

While working through the approval process, explore these cost-reduction strategies:

Manufacturer Support

Sobi Cares Patient Support Program

  • Copay assistance for eligible patients
  • Prior authorization support
  • Nurse case management
  • Contact: Visit Sobi's official website for current program details

Generic Options

Generic nitisinone may be available at lower cost, though formulation differences should be discussed with your specialist.

State and Foundation Programs

  • New York State Medicaid: May provide coverage for eligible patients
  • Rare disease foundations: Some offer emergency assistance programs
  • Hospital financial assistance: Many hospitals offer charity care programs

Frequently Asked Questions

How long does Humana prior authorization take for Orfadin? Standard prior authorization typically takes 5-7 business days. Expedited requests must be processed within 72 hours if urgent medical need is documented.

What if Orfadin isn't on Humana's formulary? You can request a formulary exception. This requires a prescriber's supporting statement explaining why formulary alternatives aren't appropriate. Humana must respond within 72 hours of receiving the prescriber's statement.

Can I get a temporary supply while waiting for approval? New Humana members may be eligible for a transition supply (up to 31 days) for non-formulary medications. Contact Humana member services to inquire about eligibility.

Does step therapy apply to Orfadin? Step therapy requirements are uncommon for Orfadin since it's the only FDA-approved treatment for HT-1. However, if step therapy is required, document medical contraindications to alternative therapies.

What happens if my appeal is denied? After exhausting Humana's internal appeals, New York residents can file an external appeal with the Department of Financial Services. Independent medical experts review the case, and their decision is binding on Humana.

How often do I need to renew prior authorization? Typically every 12-24 months, depending on your specific plan. Renewal requires updated clinical documentation showing continued medical necessity and treatment response.

At Counterforce Health, we help patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters, identifies the specific denial basis, and creates point-by-point rebuttals aligned with each plan's requirements, streamlining the appeals process for complex medications like Orfadin.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance plan for specific coverage decisions. Coverage policies and appeal processes may change; verify current requirements with official sources.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.